l 656224 has been researched along with verlukast in 1 studies
Studies (l 656224) | Trials (l 656224) | Recent Studies (post-2010) (l 656224) | Studies (verlukast) | Trials (verlukast) | Recent Studies (post-2010) (verlukast) |
---|---|---|---|---|---|
8 | 0 | 0 | 396 | 14 | 115 |
Protein | Taxonomy | l 656224 (IC50) | verlukast (IC50) |
---|---|---|---|
Multidrug resistance-associated protein 1 | Homo sapiens (human) | 2.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gyömber, E; Rainsford, KD; Szabo, S; Vattay, P | 1 |
1 other study(ies) available for l 656224 and verlukast
Article | Year |
---|---|
Effect of lipoxygenase inhibitors and leukotriene antagonists on acute and chronic gastric haemorrhagic mucosal lesions in ulcer models in the rat.
Topics: Animals; Aspirin; Benzofurans; Ethanol; Female; Gastritis; Indomethacin; Iodoacetamide; Leukotriene D4; Leukotrienes; Lipoxygenase Inhibitors; Peptic Ulcer Hemorrhage; Phenylbutyrates; Propionates; Quinolines; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1996 |